Mirae Asset Global Etfs Holdings Ltd. Artivion, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Artivion, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 19,524 shares of AORT stock, worth $491,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,524Holding current value
$491,223% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
166Shares Held
35.4MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$167 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$70.7 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$70.3 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$69.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$59.4 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.01B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...